Major Depressive Disorder

>

On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Latest News

SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial
SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial

November 1st 2024

In a recent phase 2a trial, SPN-820, a novel intracellular moderator of mTORC1, decreased suicidal ideation by 80%.

Alto Neuroscience’s ALTO-100 Fails to Beat Placebo in Improving Depressive Symptoms
Alto Neuroscience’s ALTO-100 Fails to Beat Placebo in Improving Depressive Symptoms

October 23rd 2024

FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More
FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More

October 23rd 2024

Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit
Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit

October 21st 2024

Patients with Major Depressive Disorder Have Increased Triglyceride Levels
Patients with Major Depressive Disorder Have Increased Triglyceride Levels

October 19th 2024

© 2024 MJH Life Sciences

All rights reserved.